Published in J Clin Microbiol on April 18, 2007
Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J (2012) 0.91
Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains. PLoS One (2013) 0.79
Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis. PLoS One (2013) 0.79
Precise genotyping and recombination detection of Enterovirus. BMC Genomics (2015) 0.78
Identification of a novel picornavirus in healthy piglets and seroepidemiological evidence of its presence in humans. PLoS One (2013) 0.78
Genome and infection characteristics of human parechovirus type 1: the interplay between viral infection and type I interferon antiviral system. PLoS One (2015) 0.77
Isolation and identification of a novel human parechovirus. J Gen Virol (2004) 2.64
Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41
Human parechoviruses--biology and clinical significance. Rev Med Virol (2000) 2.24
Human parechovirus 3 and neonatal infections. Emerg Infect Dis (2005) 2.02
Parechoviruses, a novel group of human picornaviruses. Ann Med (2001) 1.92
Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains. J Virol (2006) 1.87
Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis (1998) 1.74
Parechoviruses. J Virol (1999) 1.66
An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J Med Virol (1989) 1.62
Severe encephalitis associated with disseminated echovirus 22 infection. Scand J Infect Dis (1989) 1.42
Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis (2006) 1.33
Antigenic properties of human parechovirus 1. J Gen Virol (2000) 1.27
A new picornavirus isolated from bank voles (Clethrionomys glareolus). Virology (1999) 1.26
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol (2007) 4.44
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis (2006) 3.26
Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis (2002) 3.13
Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA (2004) 2.90
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine (2003) 2.87
Impact of extreme temperatures on parasitoids in a climate change perspective. Annu Rev Entomol (2007) 2.79
The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines (2012) 2.79
Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J (2003) 2.66
Genetic diversity between human metapneumovirus subgroups. Virology (2003) 2.65
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis (2010) 2.51
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther (2007) 2.46
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine (2009) 2.43
Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis (2010) 2.41
New Saffold cardioviruses in 3 children, Canada. Emerg Infect Dis (2008) 2.34
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med (2009) 2.24
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther (2006) 2.22
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. Clin Infect Dis (2005) 2.21
The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis (2006) 2.12
Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat (2002) 2.00
Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med (2005) 1.97
Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res (2003) 1.96
Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis (2004) 1.95
Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis (2006) 1.92
Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis (2004) 1.92
Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Pediatr Infect Dis J (2006) 1.86
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog (2010) 1.81
Functional ecology of immature parasitoids. Annu Rev Entomol (2004) 1.80
Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis (2008) 1.77
Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother (2010) 1.73
A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir Ther (2004) 1.73
Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis (2008) 1.72
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother (2005) 1.72
Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Clin Infect Dis (2009) 1.70
Otitis media and its consequences: beyond the earache. Lancet Infect Dis (2010) 1.68
Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis (2005) 1.64
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J Infect Dis (2011) 1.64
Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J (2004) 1.63
Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr (2010) 1.61
Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J (2009) 1.60
WU polyomavirus in children, Canada. Emerg Infect Dis (2007) 1.59
Influenza virus shedding: excretion patterns and effects of antiviral treatment. J Clin Virol (2009) 1.58
Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis (2004) 1.53
Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol (2008) 1.53
A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis (2009) 1.51
Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J (2006) 1.51
Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J (2005) 1.49
Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes to early clinical recurrence. J Infect Dis (2005) 1.49
Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6C. J Clin Microbiol (2010) 1.48
Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: a systematic review and meta-analysis. Vaccine (2011) 1.48
Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine (2008) 1.48
Influenza virus resistance to neuraminidase inhibitors. Antiviral Res (2013) 1.47
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis (2012) 1.47
Cytology of middle ear fluid during acute otitis media. Pediatr Infect Dis J (2002) 1.45
Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol (2004) 1.44
Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol (2003) 1.44
Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J Infect Dis (2007) 1.43
Relative importance of nasopharyngeal versus oropharyngeal sampling for isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age. J Clin Microbiol (2004) 1.43
Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol (2005) 1.42
Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol (2008) 1.41
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine (2004) 1.35
Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol (2009) 1.35
Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis (2006) 1.33
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res (2006) 1.32
Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis (2011) 1.31
Treatment of respiratory virus infections. Antiviral Res (2006) 1.31
What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface (2009) 1.30
Molecular characterization of a Canadian human parechovirus (HPeV)-3 isolate and its relationship to other HPeVs. J Med Virol (2005) 1.30
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis (2012) 1.29
Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines (2006) 1.29
Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res (2003) 1.29
High seroprevalence of human metapneumovirus among young children in Israel. J Infect Dis (2003) 1.29
Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis (2010) 1.28
The potential indirect effect of conjugate pneumococcal vaccines. Vaccine (2003) 1.28
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis (2002) 1.28
Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J (2005) 1.28
Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis (2005) 1.27
Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis (2007) 1.27
Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics (2009) 1.26
Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis (2004) 1.25
Influenza drug resistance. Semin Respir Crit Care Med (2011) 1.25
Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses (2011) 1.24
Estimation of vaccine efficacy against acquisition of pneumococcal carriage. Vaccine (2009) 1.23
The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers. Clin Infect Dis (2009) 1.23
Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J (2002) 1.22
Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis (2012) 1.21
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol (2009) 1.20
Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J Infect Dis (2006) 1.20
A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis (2009) 1.16
Genotyping of invasive Kingella kingae isolates reveals predominant clones and association with specific clinical syndromes. Clin Infect Dis (2012) 1.15
Human metapneumovirus genetic variability, South Africa. Emerg Infect Dis (2005) 1.15
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog (2011) 1.14
Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis (2003) 1.14
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest (2002) 1.14
Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin Vaccine Immunol (2011) 1.14
Acquisition of Streptococcus pneumoniae and nonspecific morbidity in infants and their families: a cohort study. Pediatr Infect Dis J (2005) 1.13